Erythropoietin and Erythropoietin Receptor

References

• Barber D. L., Corless C. N., Xia K., Roberts T. M.D., Andrea A. D. Erythropoietin activates Raf-1 by an She independant pathway in CTLL-Epo-R cells. Blood 1997a; 89: 55–64
   PubMed Web of Science ®Google Scholar
• Barber D. L., Mason J. M., Fukazawa T., Reedquist K. A., Druker B. J., Band H., D'Andrea A. D. Erythropoietin and Interleukin-3 activate tyrosine phosphorylation of cbl and association with crk adaptor proteins. Blood 1997b; 89: 3166–3174
   PubMed Web of Science ®Google Scholar
• Bazan J. F. Haemopoietic receptors and helical cytokines. Immunol. Today 1990a; 11: 350–354
   PubMedGoogle Scholar
• Bazan J. F. Structural design and molecular evolution of a cytokine receptor super family. Proc. Natl. Acad. Set., USA 1990b; 87: 6934–6938
   PubMed Web of Science ®Google Scholar
• Beck I., Weinmann R., Caro J. Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood 1993; 82: 704–711
   PubMed Web of Science ®Google Scholar
• Benito A., Silva M., Grillot D., Nunez G., Fernandezluna J. L. Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-X(L). Blood 1996; 87: 3837–3843
   PubMed Web of Science ®Google Scholar
• Bittorf T., Jaster R., Brock J. Rapid activation of the MAP kinase pathway in hematopoietic cells by erythropoietin, granulocyte-macrophage-colony stimulating factor and interleukin-3. Cell Signal. 1994; 6: 305–311
   PubMed Web of Science ®Google Scholar
• Carroll M. P., Spivak J. L., McMahon M., Weich N., Rapp U. R., May W. S. Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J. Biol. Chem. 1991; 266: 14964–14969
   PubMed Web of Science ®Google Scholar
• Chappell D., Tilbrook P. A., Bittorf T., Colley S. M., Meyer G. T., Klinken S. P. Prevention of apoptosis in J2E erythroid cells by erythropoietin: involvement of JAK2 but not MAP kinases. Cell Death Differ. 1997; 4: 105–113
   PubMed Web of Science ®Google Scholar
• Chin H., Saito T., Arai A., Yamamoto K., Kimayama R., Miyasaka N., Miura O. Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with She, SHP-2 and cbl in hematopoietic cells. Biochem. Biophys. Res. Comm. 1997a; 239: 412–417
   PubMed Web of Science ®Google Scholar
• Chin H., Wakao H., Miyajima A., Kimayama R., Miyasaka N., Miura O. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (beta(IL3) and recruitment of STAT5 to possible STAT5-docking sites in beta(IL3). Blood 1997b; 89: 89–4327
   Web of Science ®Google Scholar
• Chin H., Arai A., Wakao H., Kimayama R., Miyasaka N., Miura O. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the STAT5 pathway. Blood 1998; 91: 3734–3745
   PubMed Web of Science ®Google Scholar
• Chretien S., Varlet P., Verdier F., Gobert S., Cartron J.-P., Gisselbrecht S., Mayeux P., Lacombe C. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5activation. EMBO J. 1996; 15: 4174–4181
   PubMed Web of Science ®Google Scholar
• Cutler R. L., Liu L., Damen J. L., Krystal G. Multiple cytokines induce the tyrosine phosphorylation of She and its association with Grb2 in haemopoietic cells. J. Biol. Chem. 1993; 268: 21463–21465
   PubMed Web of Science ®Google Scholar
• D'Andrea A. D., Lodish H. F., Wong G. G. Expression cloning of the murine erythropoietin receptor. Cell 1989; 57: 277–285
   PubMed Web of Science ®Google Scholar
• D'Andrea A. D., Zon L. I. Erythropoietin receptor. Subunit structure and activation. J. Clin. Invest. 1990; 86: 681–687
   PubMed Web of Science ®Google Scholar
• D'Andrea A. D., Yoshimura A., Yousoufian H., Zon L. I., Koo J.-W., Lodish H. F. The cytoplasmic region of the erythropoietin receptor contains non-overlapping positive and negative growth-regulatory domains. Mol. Cell. Biol. 1991; 11: 1980–1987
   PubMed Web of Science ®Google Scholar
• Damen J. E., Mui A. L.-F., Puil L., Pawson T., Krystal G. Phosphatidyl inositol-3 kinase associates, via its SRC homology 2 domains, with activated erythropoietin receptor. Blood 1993; 81: 3204–3210
   PubMed Web of Science ®Google Scholar
• Damen J. E., Cutler R. L., Huaiyuan J., Yi T., Krystal G. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the p85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity. J. Biol. Chem. 1995a; 270: 23402–23408
   PubMed Web of Science ®Google Scholar
• Damen J. E., Wakao H., Miyajima A., Krosl J., Humphries R. K., Cutler R. K., Krystal G. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 1995b; 14: 5557–5568
   PubMed Web of Science ®Google Scholar
• de la Chapelle A., Traskelin A.-L., Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc. Natl. Acad. Sci., USA 1993; 90: 4495–4499
   PubMed Web of Science ®Google Scholar
• Duprez V., Blank U., Chretien S., Gisselbrecht S., Mayeux P. Physical and functional interaction between p72syk and erythropoietin receptor. J. Biol. Chem. 1998; 273: 33985–33990
   PubMed Web of Science ®Google Scholar
• Dusanter-Fourt I., Casadevall N., Lacombe C., Muller O., Billat C., Fischer S., Mayeux P. Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. J. Biol. Chem. 1992; 267: 10670–10675
   PubMed Web of Science ®Google Scholar
• Ehrenman K., St John T. The erythropoietin receptor gene: Cloning and identification of multiple transcripts in an erythroid cell line. Exp. Hematol. 1991; 19: 973–977
   PubMed Web of Science ®Google Scholar
• Endo T. A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui H., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita Y., Kanakura Y., Komiya S., Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387: 921–924
   PubMed Web of Science ®Google Scholar
• Fraser J. K., Lin F.-K., Berridge M. V. Expression of high affinity receptors for erythropoietin on human bone marrow cells and on the human erythroleukemic cell line, HEL. Exp. Hematol. 1988; 16: 836–842
   PubMed Web of Science ®Google Scholar
• Gobert S., Duprez V., Lacombe C., Gisselbrecht S., Mayeux P. The signal transduction pathway of erythropietin involves three forms of mitogen-activated protein (MAP) kinase in UT7 erythroleukemic cells. Eur. J. Biochem. 1995; 234: 75–83
   PubMedGoogle Scholar
• Gobert S., Chretien S., Gouileux F., Muller O., Pallard C., Dusanter-Fourt I., Groner B., Lacombe C., Gisselbrecht S., Mayeux P. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J. 1996; 15: 2434–2441
   PubMed Web of Science ®Google Scholar
• Gregoli P. A., Bondurant M. C. The roles of Bcl-XL and apopain in the control of erythropoiesis by erythropoietin. Blood 1997; 90: 630–640
   PubMed Web of Science ®Google Scholar
• Gregory R. C., Jiang N., Todokoro K., Crouse J., Pacifici R. E., Wojchowski D. M. Erythropoietin receptor and STAT5-specific pathways promote SKT6 cell hemoglobinization. Blood 1998; 92: 1104–1118
   PubMed Web of Science ®Google Scholar
• Hanazono Y., Chiba S., Sasaki K., Mano H., Yazaki Y., Hirai H. Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes protooncogene product in human erythropoietin-responsive cells. Blood 1993; 81: 3193–3196
   PubMed Web of Science ®Google Scholar
• Hanazono Y., Sakasi K., Nitta H., Yazaki Y., Hirai H. Erythropoietin induces tyrosine phosphorylation of the beta chain of the GM-CSF receptor. Biochem. Biophys. Res. Comm. 1995; 208: 1060–1066
   PubMed Web of Science ®Google Scholar
• He T.-C., Jiang N., Zhuang H., Wojchowski D. M. Erythropoietin-induced recruitment of She via a receptor phosphotyrosine induced, Jak 2 associated pathway. J. Biol. Chem. 1995; 270: 11055–11061
   PubMed Web of Science ®Google Scholar
• Hilton D. J., Watowich S. S., Murray P. J., Lodish H. F. Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor. Proc. Natl. Acad. Sci., USA 1995; 92: 190–194
   PubMed Web of Science ®Google Scholar
• Hilton D. J., Watowich S. S., Katz L., Lodish H. F. Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor. J. Biol. Chem. 1996; 271: 4699–4708
   PubMed Web of Science ®Google Scholar
• Iwatsuki K., Endo T., Misawa H., Yokouchi M., Matsumoto M., Ohtsubo M., Mori K. J., Yoshimura A. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line. J. Biol. Chem. 1997; 272: 8149–8152
   PubMed Web of Science ®Google Scholar
• Jacobs J., Shoemaker C., Rudersdorf R., Neill S. D., Kaufman A., Mufson A., Seehra J., Jones S. S., Hewick R., Fritsch E. F., Kawakita M., Shimuzu T., Miyake T. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985; 313: 806–810
   PubMed Web of Science ®Google Scholar
• Jacobs-Helber S. M., Penta K., Sun Z., Lawson A., Sawyer S. T. Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J. Biol. Chem. 1997; 272: 6850–6853
   PubMed Web of Science ®Google Scholar
• Joneja B., Chen H. C., Seshasayee D., Wrentmore A. L., Wojchowski D. M. Mechanisms of stem cell factor and erythropoietin proliferative co-signaling in FDC2-ER cells. Blood 1997; 90: 3533–3545
   PubMed Web of Science ®Google Scholar
• Jubinsky P. T., Krijanovski O. I., Nathan D. G., Tavernier J., Sieff C. A. The β chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood 1997; 90: 1867–1873
   PubMed Web of Science ®Google Scholar
• Kirito K., Uchida M., Yamada M., Miura Y., Komatsu N. A distinct function of STAT proteins in erythropoietin signal transduction. J Biol. Chem. 1997; 272: 16507–16513
   PubMed Web of Science ®Google Scholar
• Kirito K., Uchida M., Takatoku M., Nakajima K., Hirano T., Miura Y., Komatsu N. A novel function of Statl α and Stat3 proteins in erythropoietin-induced erythroid differentiation of a human leukemia cell line. Blood 1998; 92: 462–471
   PubMed Web of Science ®Google Scholar
• Klingmuller U., Lorenz U., Cantley L. C., Neel B. G., Lodish H. F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995; 80: 729–738
   PubMed Web of Science ®Google Scholar
• Klingmuller U., Bergelson S., Hsiao J. G., Lodish H. F. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5. Proc. Natl. Acad. Sci., USA 1996; 93: 8324–8328
   PubMed Web of Science ®Google Scholar
• Klingmuller U., Wu H., Hsiao J. G., Toker A., Duckworth B. C., Cantley L. C., Lodish H. F. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc. Natl. Acad. Sci. USA 1997; 94: 3016–3021
   PubMed Web of Science ®Google Scholar
• Klinken S. P., Nicola N. A., Johnson G. R. In vitro-derived leukemic cell lines induced by a raf- and myc-containing retrovirus differentiate in response to erythropoietin. Proc. Natl. Acad. Sci., USA 1988; 85: 8506–8510
   PubMed Web of Science ®Google Scholar
• Koury M. J., Bondurant M. C., Atkinson J. B. Erythropoietin control of terminal erythroid differentiation: maintenance of cell viability, production of hemoglobin and development of the erythrocyte membrane. Blood Cells 1987; 13: 217–226
   PubMedGoogle Scholar
• Koury S. T., Bondurant M. C., Graber S. E., Sawyer S. T. Erythropoietin messenger RNA levels in developing mice and transfer of 125I-erythropoietin by placenta. J. Clin. Invest. 1988a; 82: 154–159
   PubMed Web of Science ®Google Scholar
• Koury S. T., Bondurant M. C., Koury M. J. Localisation of erythropoietin synthesising cells in murine kidneys by in situ hybridisation. Blood 1988b; 71: 524–527
   PubMed Web of Science ®Google Scholar
• Koury M. J., Bondurant M. C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990; 248: 378–381
   PubMed Web of Science ®Google Scholar
• Koury ST., Bondurant M. C., Koury M. J., Semenza G. L. Localisation of cells producing erythropoietin in murine liver by in situ hybridisation. Blood 1991; 77: 2497–2503
   PubMed Web of Science ®Google Scholar
• Krantz S. B. Erythropoietin. Blood 1991; 71: 419–434
   Google Scholar
• Kuramochi S., Ikawa Y., Todokoro K. Characterization of murine erythropoietin receptor genes. J. Mol. Biol. 1990; 216: 567–757
   PubMed Web of Science ®Google Scholar
• Lacronique V., Varlet P., Mayeux P., Porteu A., Gisselbrecht A., Kahn A., Lacombe C. Bcl-2 targetted over-expression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors. Blood 1997; 90: 3050–3056
   PubMed Web of Science ®Google Scholar
• Landschulz K. T., Noyes A. N., Rogers O., Boyer S. J. Erythropoietin receptors on murine erythroid colony-forming units: Natural history. Blood 1989; 73: 1476–1486
   PubMed Web of Science ®Google Scholar
• Liu L., Damen J. E., Cutler R. L., Krystal G. Multiple cytokines stimulate the binding of a common 145 Kd protein to She at the Grb2 recognition site of She. Mol. Cell. Biol. 1994; 14: 6926–6935
   PubMed Web of Science ®Google Scholar
• Longmore G. D., Lodish H. F. An activating mutation in the murine erythopoietin receptor induces erythroleukemia in mice. A cytokine superfamily oncogene. Cell 1991; 61: 1089–1102
   Google Scholar
• Longmore G. D., Pharr P. N., Lodish H. F. A constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multi-potent, committed nonerythroid and erythroid progenitor cells. Mol. Cell. Biol. 1994; 14: 2266–2277
   PubMed Web of Science ®Google Scholar
• Machide M., Mano H., Todokoro K. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain. Oncogene 1995; 11: 619–625
   PubMed Web of Science ®Google Scholar
• Masuda S., Okano M., Yamagishi K., Nagao M., Ueda M., Sasaki R. A novel site of erythropoietin production - oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem. 1994; 269: 19488–19493
   PubMed Web of Science ®Google Scholar
• Matsumoto A., Masuhara M., Mitsui K., Yokouchi M., Ohtsubo M., Misawa H., Miyajima A., Yoshimura A. CIS, a Cytokine Inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 1997; 89: 89–3148
   Web of Science ®Google Scholar
• Matthews D. J., Topping R. S., Cass R. T., Giebel L. B. A sequential dimerization mechanism for erythropoietin receptor activation. Proc. Natl. Acad. Sci., USA 1996; 93: 9471–9486
   PubMed Web of Science ®Google Scholar
• Maxwell P. H., Ferguson D. J.P., Osmond M. K., Pugh C. W., Heryet A., Doe B. G., Johnson M. H., Ratcliffe P. J. Expression of a homologously recombined erythro-poietin-SV40 T antigen fusion gene in mouse liver - evidence for erythropoietin production by Ito cells. Blood 1994; 84: 1823–1830
   PubMed Web of Science ®Google Scholar
• Mayeux P., Dusanter-Fourt I., Muller O., Maduit P., Sabbah M., Druker B., Vainchenker W., Fisher S., Lacombe C., Gisselbrecht S. Erythropoietin induces the association of phosphatidylinositol 3′-kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor. Eur. J. Biochem. 1993; 216: 821–828
   PubMedGoogle Scholar
• McDonald J. D., Lin F. K., Goldwasser E. Cloning, sequencing, and evolutionary analysis of the mouse erythropoietin gene. Mol. Cell. Biol. 1986; 6: 842–848
   PubMed Web of Science ®Google Scholar
• Migliaccio A. R., Jiang Y., Migliaccio G., Nicolis S., Crotta S., Ronchi A., Ottolenghi S., Anderson J. W. Transcriptional and posttranscriptional regulation of the expression of the erythropoietin receptor gene in human erythropoietin-responsive cell lines. Blood 1993; 82: 3760–3769
   PubMed Web of Science ®Google Scholar
• Miura O. D., Andrea A., Kabat D., Ihle J. N. Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol. Cell. Biol. 1991; 11: 4895–4902
   PubMed Web of Science ®Google Scholar
• Miura O., Cleveland J. L., Ihle J. N. Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors. Mol. Cell. Biol. 1993; 13: 1788–1795
   PubMed Web of Science ®Google Scholar
• Miura O., Ihle J. N. Dimer- and oligomerization of the erythropoietin receptor by disulfide bond formation and significance of the region near the WSXWS motif in intracellular transport. Arch. Biochem. Biophys. 1993; 306: 200–208
   PubMed Web of Science ®Google Scholar
• Miura O., Nakamura N., Ihle J., Aoki N. Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine phosphorylated erythropoietin receptor. J. Biol. Chem. 1994a; 269: 614–620
   PubMed Web of Science ®Google Scholar
• Miura O., Nakamura N., Quelle F. W., Witthuhn B. A., Ihle J. N., Aoki N. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin recepto. in vivo. Blood 1994b; 84: 1501–1507
   PubMed Web of Science ®Google Scholar
• Miura Y., Miura O., Ihle J. N., Aoki N. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J. Biol. Chem. 1994c; 269: 29962–29969
   PubMedGoogle Scholar
• Motoyama N., Wang F. P., Roth K. A., Sawa H., Nakayama K., Nakayama K., Negishi I., Senju S., Zhang Q., Fujii S., Loh D. Y. Massive cell death of immature hematopoietic cells and neurons in Bcl-X deficient mice. Blood 1995; 267: 1506–1510
   Google Scholar
• Murakami M., Barazaju M., Hubu M., Yawata H., Yasukawa K., Hamaguchi M., Taga T., Kishimots T. Critical cytoplasmic region of the interleukin 6 signal transducer gp 130 is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci., USA 1991; 90: 11349
   Google Scholar
• Nagata Y., Moriguchi T., Nishida E., Todokoro K. Activation of p38 MAP Kinase pathway by erythropoietin and interleukin-3. Blood 1997a; 90: 929–934
   PubMed Web of Science ®Google Scholar
• Nagata Y., Nishida E., Todokoro K. Activation of JNK signalling pathway by erythropoietin, thrombopoietin and interleukin-3. Blood 1997b; 89: 2664–2669
   PubMed Web of Science ®Google Scholar
• Nagata Y., Takahashi N., Davis R. J., Todokoro K. Activation of p38 MAP Kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 1998; 92: 1859–1869
   PubMed Web of Science ®Google Scholar
• Nakamura Y., Komatsu N., Nakauchi H. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 1992; 257: 1138–1141
   PubMed Web of Science ®Google Scholar
• Neubauer H., Cumano A., Muller M., Wu H., Huffstadt U., Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 1998; 93: 397–409
   PubMed Web of Science ®Google Scholar
• Neumann D., Wikstrom L., Watowich S. S., Lodish H. F. Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosymes. J. Biol. Chem. 1993; 268: 13639–13649
   PubMed Web of Science ®Google Scholar
• Odai H., Sasaki K., Iwamatsu A., Hanazono Y., Tanaka T., Mitani K., Yazaki Y., Hirai H. The protooncogene product c-cbl become tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb/Ash in human hematopoietic cells. J. Biol. Chem. 1995; 270: 10800–10806
   PubMed Web of Science ®Google Scholar
• Ohashi T., Masuda M., Ruscetti S. K. Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus. Blood 1995; 85: 1454–1462
   PubMed Web of Science ®Google Scholar
• Parganas E., Wang D., Stravopodis D., Topham D. J., Marine J.-C., Teglund S., Vanin E. F., Bodner S., Colamonici O. R., van Deursen J. M., Grosveld G., Ihle J. N. Jak2 Is essential for signaling through a variety of cytokine receptors. Cell 1998; 93: 93–385
   PubMed Web of Science ®Google Scholar
• Penny L. A., Forget B. G. Genomic organization of the human erythropoietin receptor gene. Genomics 1991; 11: 974–979
   PubMed Web of Science ®Google Scholar
• Penta K., Sawyer S. T. Erythropoietin induces the tyrosine phopshporylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells. J. Biol. Chem. 1995; 270: 31282–31287
   PubMed Web of Science ®Google Scholar
• Quelle F. W., Wang D., Nosaka T., Thierfelder W. E., Stravapodis D., Wemstein Y., Ihle J. N. Erythropoietin induces activation of ST AT 5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 1996; 16: 1622–1631
   PubMed Web of Science ®Google Scholar
• Recny M. A., Scoble H. A., Kim Y. Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. J. Biol. Chem. 1987; 262: 17156–17163
   PubMed Web of Science ®Google Scholar
• Ren H. Y., Komatsu N., Shimizu R., Okada K., Miura Y. Erythropoietin induces tyrosine phosphorylation and activation of phospholipase C-gamma-1 In a human erythropoietin-dependent cell line. J. Biol. Chem. 1994; 269: 19633–19638
   PubMed Web of Science ®Google Scholar
• Sawyer S. T., Koury M. J. Erythropoietin requirements during terminal erythroid differentiation: the role of surface receptors for erythropoietin. J. Cell. Biol. 1987; 105: 1077
   Google Scholar
• Sawyer S. T., Hankins W. D. The functional form of the erythropoietin receptor is a 78 kDa protein: Correlation with cell surface expression, endocytosis, and phosphorylation. Proc. Natl. Acad. Sci., USA 1993; 90: 6849–6853
   PubMed Web of Science ®Google Scholar
• Schuster S. J., Badiavas E. V., Costa-Giomi P., Weinmann R., Erslev A. J., Caro J. Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure. Blood 1994; 84: 1823–1830
   PubMedGoogle Scholar
• Shigematsu H., Iwasaki H., Otsuka T., Ohno Y., Arima F., Niho Y. Role of the vav protooncogene product (vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity. J. Biol. Chem. 1997; 272: 14334–14340
   PubMed Web of Science ®Google Scholar
• Silva M., Grillot D., Benito A., Richard C., Nunez G., Fernandez-Luna J. L. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 1996; 88: 1576–1582
   PubMed Web of Science ®Google Scholar
• Starr R., Willson T. A., Viney E. M., Murray L. J., Rayner J. R., Jenkins B. J., Gonda T. J., Alexander W. S., Metcalf D., Nicola N. A., Hilton D. J. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387: 917–921
   PubMed Web of Science ®Google Scholar
• Tauchi T., Feng G.-S., Shen R., Hoatlin M., Bagby G. C., Kabat D., Lu L., Broxmeyer H. E. Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J. Biol. Chem. 1995; 270: 5631–5635
   PubMed Web of Science ®Google Scholar
• Tauchi T., Damen J. E., Toyama K., Feng G.-S., Broxmeyer H. E., Krystal G. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation and promotes mitogenesis. Blood 1996; 87: 4495–4501
   PubMed Web of Science ®Google Scholar
• Tilbrook P. A., Bittorf T., Callus B., Busfield S. J., Ingley E., Klinken S. P. Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells. Cell Growth Differ. 1996a; 7: 511–520
   PubMedGoogle Scholar
• Tilbrook P. A., Bittorf T., Busfield S. J., Chappell D., Klinken S. P. Disrupted signaling in a mutant J2E cell line that shows enhanced viability, but does not proliferate or differentiate, with erythropoietin. J. Biol. Chem. 1996b; 271: 3453–3459
   PubMed Web of Science ®Google Scholar
• Tilbrook P. A., Ingley E., Williams J. H., Hibbs M. L., Klinken S. P. Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells. EMBO J. 1997; 16: 1610–1619
   PubMed Web of Science ®Google Scholar
• Torti M., Marti K. B., Altschuler D., Yamamoto K., Lapetina E. G. Erythropoietin induces p21ras activation and p120Gap tyrosine phosphorylation in human erythroleukemic cells. J. Biol Chem. 1992; 267: 8293–8298
   PubMed Web of Science ®Google Scholar
• Tsushima H., Urata Y., Miyazaki Y., Fuchigami K., Kuriyama K., Kondo T., Tomonaga M. Human erythropoietin receptor increases Gata-2 and Bcl-X(L) by a Protein Kinase C., dependent pathway in human erythropoietin-dependent cell line As-E2. Cell Growth Differ. 1997; 8: 1317–1328
   PubMedGoogle Scholar
• Veis D. J., Sorenson C. M., Shutter J. R., Korsmeyer S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75: 229–240
   PubMed Web of Science ®Google Scholar
• Verdier F., Chretien S., Billat C., Gisseibrecht S., Lacombe C., Mayeux P. Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2 - an alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation. J. Biol. Chem. 1997; 272: 26173–26178
   PubMed Web of Science ®Google Scholar
• Verdier F., Chretien S., Muller O., Varlet P., Yoshimura A., Gisseibrecht S., Lacombe C., Mayeux P. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. J. Biol. Chem. 1998; 273: 28185–28190
   PubMed Web of Science ®Google Scholar
• Wakao H., Chida D., Damen J. E., Krystal G., Miyajima A. A possible involvement of Stat5 In erythropoietin-induced hemoglobin synthesis. Biochem. Biophys. Res. Comm. 1997; 234: 198–205
   PubMed Web of Science ®Google Scholar
• Wang G. L., Semenza G. L. Characterization of Hypoxia-Inducible Factor-1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 1993; 268: 21513–21518
   PubMed Web of Science ®Google Scholar
• Watowich S. S., Yoshimura A., Longmore G. D., Hilton D. J., Yoshimura Y., Lodish H. F. Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl. Acad. Sci., USA 1992; 89: 2140–2144
   PubMed Web of Science ®Google Scholar
• Watowich S. S., Hilton D. J., Lodish H. F. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol. Cell. Biol. 1994; 14: 3535–3549
   PubMed Web of Science ®Google Scholar
• Wickrema A., Bondurant M. C., Krantz S. B. Abundance and stability of erythropoietin receptor mRNA in mouse erythroid progenitor cells. Blood 1991; 78: 2269–2275
   PubMed Web of Science ®Google Scholar
• Wickrema A., Krantz S. B., Winkelmann J. C., Bondurant M. C. Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood 1992; 80: 1940–1949
   PubMed Web of Science ®Google Scholar
• Witthuhn B. A., Quelle F. W., Silvennoinen O., Yi T., Tang B., Miura O., Ihle J. N. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993; 74: 227–236
   PubMed Web of Science ®Google Scholar
• Wu H., Lui X., Jaenisch R., Lodish H. F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995a; 83: 59–67
   PubMed Web of Science ®Google Scholar
• Wu H., Klingmuller U., Besmer P., Lodish H. F. Interaction of the erythropoietin and stem-cell-factor receptors. Nature 1995b; 377: 242–246
   PubMed Web of Science ®Google Scholar
• Wu H., Klingmuller U., Acurio A., Hsiao J. G., Lodish H. F. Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc. Natl. Acad. Sci., USA 1997; 94: 1806–1810
   PubMed Web of Science ®Google Scholar
• Yi T., Zhang J., Muira O., Ihle J. N. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: Identification of potential binding sites. Blood 1995; 85: 87–95
   PubMed Web of Science ®Google Scholar
• Yoshimura A. D., Andrea A. D., Lodish H. F. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Proc. Natl. Acad. Sci., USA 1990; 87: 4139–4143
   PubMed Web of Science ®Google Scholar
• Yoshimura A., Lodish H. F. In-vitro phosphorylation of the erythropoietin receptor and an associated protein, p. 130. Mol. Cell. Biol. 1992; 12: 706–715
   PubMed Web of Science ®Google Scholar
• Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N. A., Gilbert D. J., Copeland N. G., Hara T., Miyajima A. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 1995; 14: 2816–2826
   PubMed Web of Science ®Google Scholar
• Youssoufian H., Longemore G., Neumann D., Yoshimura A., Lodish H. F. Structure function and activation of the erythropoietin receptor. Blood 1993; 81: 2223–2236
   PubMed Web of Science ®Google Scholar
• Zhuang H., Patel S. V., He T.-C., Sonsteby S. K., Niu Z., Wojchowski D. M. Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. J. Biol. Chem. 1994; 269: 21411–21414
   PubMed Web of Science ®Google Scholar